ICOA
ALXN

Investment Centers of America’s Alexion Pharmaceuticals ALXN Stock Holding History

Investment Centers of America’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,307
Closed -$216K – 449
2014
Q3 		$216K Buy
1,307
+7
+0.5% +$1.15K 0.04% 368
2014
Q2 		$204K Buy
+1,300
New +$205K 0.05% 317

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Investment Centers of America's ALXN Position: Q4 2014 in Review

Investment Centers of America sold out of Alexion Pharmaceuticals (ALXN) in Q4 2014, closing a stake of 1,307 shares — an estimated $216K sold.

Investment Centers of America first reported a position in ALXN in Q2 2014 and held it in 2 quarters. The position peaked at $216K in Q3 2014. 579 funds tracked by Wall St. Rank hold ALXN as of Q4 2014.

  • Investment Centers of America reported no remaining Alexion Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Investment Centers of America sold 1,307 Alexion Pharmaceuticals shares in Q4 2014, an estimated $216K.
  • Investment Centers of America first reported a position in Alexion Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Investment Centers of America's Alexion Pharmaceuticals position peaked at $216K in Q3 2014.
  • 579 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2014.

Based on Investment Centers of America's 13F filing for Q4 2014, filed 6 Feb 2015.